Carolinas Wealth Consulting’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12
| Closed | -$1.84K | – | 1023 |
|
|
2024
Q4 | $1.84K | Buy |
12
+10
| +500% | +$1.53K | ﹤0.01% | 843 |
|
|
2024
Q3 | $388 | Sell |
2
-3
| -60% | -$582 | ﹤0.01% | 1022 |
|
|
2024
Q2 | $1.16K | Hold |
5
| – | – | ﹤0.01% | 886 |
|
|
2024
Q1 | $1.08K | Sell |
5
-51
| -91% | -$11K | ﹤0.01% | 884 |
|
|
2023
Q4 | $14.5K | Hold |
56
| – | – | ﹤0.01% | 492 |
|
|
2023
Q3 | $13.3K | Hold |
56
| – | – | ﹤0.01% | 486 |
|
|
2023
Q2 | $16K | Hold |
56
| – | – | ﹤0.01% | 515 |
|
|
2023
Q1 | $15.6K | Sell |
56
-15
| -21% | -$4.17K | ﹤0.01% | 533 |
|
|
2022
Q4 | $19.7K | Sell |
71
-6
| -8% | -$1.66K | ﹤0.01% | 499 |
|
|
2022
Q3 | $21K | Hold |
77
| – | – | 0.01% | 436 |
|
|
2022
Q2 | $16K | Sell |
77
-10
| -11% | -$2.08K | ﹤0.01% | 489 |
|
|
2022
Q1 | $18K | Sell |
87
-20
| -19% | -$4.14K | ﹤0.01% | 500 |
|
|
2021
Q4 | $26K | Buy |
107
+2
| +2% | +$486 | 0.01% | 441 |
|
|
2021
Q3 | $30K | Buy |
105
+7
| +7% | +$2K | 0.01% | 411 |
|
|
2021
Q2 | $34K | Buy |
98
+10
| +11% | +$3.47K | 0.01% | 414 |
|
|
2021
Q1 | $25K | Sell |
88
-52
| -37% | -$14.8K | 0.01% | 472 |
|
|
2020
Q4 | $34K | Buy |
140
+87
| +164% | +$21.1K | 0.01% | 394 |
|
|
2020
Q3 | $15K | Buy |
53
+49
| +1,225% | +$13.9K | 0.01% | 424 |
|
|
2020
Q2 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 542 |
|